Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) EPS (Basic): 2011-2024

Historic EPS (Basic) for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $0.85.

  • Adma Biologics' EPS (Basic) changed negligibly% to $0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.88, marking a year-over-year increase of 203.45%. This contributed to the annual value of $0.85 for FY2024, which is 753.85% up from last year.
  • Latest data reveals that Adma Biologics reported EPS (Basic) of $0.85 as of FY2024, which was up 753.85% from -$0.13 recorded in FY2023.
  • Adma Biologics' EPS (Basic)'s 5-year high stood at $0.85 during FY2024, with a 5-year trough of -$0.88 in FY2020.
  • For the 3-year period, Adma Biologics' EPS (Basic) averaged around $0.13, with its median value being -$0.13 (2023).
  • Data for Adma Biologics' EPS (Basic) shows a peak YoY surged of 753.85% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Adma Biologics' EPS (Basic) stood at -$0.88 in 2020, then spiked by 42.05% to -$0.51 in 2021, then soared by 35.29% to -$0.33 in 2022, then spiked by 60.61% to -$0.13 in 2023, then skyrocketed by 753.85% to $0.85 in 2024.